Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.
Click to see more
Moderna, Inc. Details
Operating Status:Active
Business TypePublic
HeadquartersCambridge, Massachusetts, United States
The Dow Jones dipped by 130 points as tech stocks plummeted during the Thursday’s volatile trading session. Pharmaceutical stocks are doing better these days.
Moderna COVID-19 vaccine candidate dubbed mRNA-1273 has entered its late-stage trials. The company noted that as of Wednesday, September 16, 2020, about 25,296 participants have been enrolled.
Stock markets are rallying as AstraZeneca resumes work after a short break in its clinical trials of the COVID-19 vaccine.
At Coinspeaker we use cookies in order to improve site performance, offer you a better browsing experience and enable you to easily share content.AcceptPrivacy policy
